Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by LivaNova PLC
< Previous
1
2
3
Next >
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
June 05, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
June 04, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Jefferies Global Healthcare Conference
May 15, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
May 07, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
May 07, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2025 Results
March 26, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Guidance
February 25, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Barclays Global Healthcare Conference
February 21, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
January 21, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
January 06, 2025
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
December 18, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting
December 05, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
November 14, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
November 11, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Third-Quarter 2024 Results
October 30, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Appoints Susan Podlogar as a New Director
October 08, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Third-Quarter 2024 Results
September 25, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Baird Global Healthcare Conference
August 19, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Second-Quarter 2024 Results
July 31, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Second-Quarter 2024 Results
June 18, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
June 06, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Goldman Sachs Healthcare Conference
May 23, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2024 Results
May 01, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
April 30, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
April 25, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2024 Results
March 21, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
March 20, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
March 05, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
March 04, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
February 21, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
